Back to search

Article

Proteomic Predictors of Baricitinib Response in Severe Alopecia Areata: CCL11 Flags a Refractory Phenotype

2025-11-26

Abstract excerpt

<h4>Background: </h4> Alopecia areata (AA) is an autoimmune disorder characterized by non-scarring hair loss. Janus kinase inhibitors (JAKi), such as baricitinib, show therapeutic benefit; however, the underlying mechanisms and reliable predictors of response remain insufficiently defined. <h4>Methods: </h4>: In this real-world study, 74 Chinese patients with severe AA received baricitinib for up to 36 weeks. Cli...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a6210266-ef34-51cc-8737-747c25574f10
DOI
10.22541/au.176415513.33647330/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Proteomic Predictors of Baricitinib Response in Severe Alopecia Areata: CCL11 Flags a Refractory PhenotypeDOI 10.22541/au.176415513.33647330/v1
Select a neighboring publication to make it the new centre.